Genomic diagnosis and multisystem phenotyping in pediatric congenital analbuminemia: clinical, coagulation, and immune signatures - Takeaways - MDSpire

Genomic diagnosis and multisystem phenotyping in pediatric congenital analbuminemia: clinical, coagulation, and immune signatures

  • By

  • Asena Pinar Sefer

  • Melek Yorgun Altunbas

  • Baran Erman

  • Salim Can

  • Alper Bulutoglu

  • Satanay Hubrack

  • Katherine Ford

  • Melanie Makhlouf

  • Luis R. Saraiva

  • Gizem Onder

  • Ozden Hatirnaz

  • Ayse Merve Usta

  • Dilek Guller

  • Dilek Baser

  • Gamze Akgun

  • Umran Aba

  • Rahmi Kutay Erdogan

  • Omer Faruk Beser

  • Fugen Cullu Cokugras

  • Fatma Demirbas Ar

  • Nafiye Urganci

  • Oguz Salih Dincer

  • Sevgi Bilgic Eltan

  • Safa Baris

  • Elif Karakoc-Aydiner

  • Bernice Lo

  • Ahmet Ozen

  • June 2, 2026

  • 0 min

Share

  • 1

    Congenital analbuminemia (CAA) is a rare autosomal recessive disorder caused by pathogenic variants in the ALB gene, leading to severe hypoalbuminemia.

  • 2

    Pediatric patients with CAA exhibit multisystem manifestations, including edema, gastrointestinal issues, recurrent infections, and dyslipidemia.

  • 3

    Genetic testing identified specific mutations in the ALB gene among the studied children, confirming the diagnosis of CAA.

  • 4

    Coagulation profiling revealed a prothrombotic signature in CAA patients, with one case resulting in life-threatening cerebral thrombosis.

  • 5

    This study emphasizes the need for early molecular diagnosis of CAA to prevent misdiagnosis and facilitate tailored monitoring for complications.

Original Source(s)

Related Content